Robert S. McKelvie
HHSC-General Division
Ontario
Canada
Name/email consistency: high
- The CHARM program: the effects of candesartan for the management of patients with chronic heart failure. McKelvie, R.S. Expert. Rev. Cardiovasc. Ther (2009)
- Exercise training in patients with heart failure: clinical outcomes, safety, and indications. McKelvie, R.S. Heart. Fail. Rev (2008)
- Current and future uses of candesartan in the treatment of heart failure. McKelvie, R.S. Future. Cardiol (2006)
- Initial data supporting the design of the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programme. McKelvie, R.S. J. Hypertens. Suppl (2006)
- Candesartan for the management of heart failure: more than an alternative. McKelvie, R.S. Expert. Opin. Pharmacother (2006)
- The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure. McKelvie, R.S. Expert. Opin. Investig. Drugs (2004)
- Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. McKelvie, R.S., Rouleau, J.L., White, M., Afzal, R., Young, J.B., Maggioni, A.P., Held, P., Yusuf, S. Eur. Heart J. (2003)